Aceto, G., D'Addato, O., Messina, G., Carbone, V., Cavallo, L., Brunetti,
G., and Faienza, M. F. (2014). Bone health in children and
adolescents with steroid-sensitive nephrotic syndrome assessed by
DXA and QUS. Pediatr. Nephrol. 29, 2147-2155.
Ahmed, S. F., Tucker, P., Mushtaq, T., Wallace, A. M., Williams, D. M.,
and Hughes, I. A. (2002). Short-term effects on linear growth and
bone turnover in children randomized to receive prednisolone or
dexamethasone. Clin. Endocrinol. (Oxf) 57, 185-191.
Araya, C. E., Wasserfall, C. H., Brusko, T. M., Mu, W., Segal, M. S.,
Johnson, R. J., and Garin, E. H. (2006). A case of unfulfilled
expectations. Cytokines in idiopathic minimal lesion nephrotic
syndrome. Pediatr. Nephrol. 21, 603-610.
Bath, L. F., Crofton, P. M., Evans, A. E., Ranke, M. B., Elmlinger, M.
W., Kelnar, C. J., and Wallace, W. H. (2004). Bone turnover and
growth during and after chemotherapy in children with solid tumors.
Pediatr. Res. 55, 224-230.
Biyikli, N. K., Emre, S., Sirin, A., and Bilge, I. (2004). Biochemical
bone markers in nephrotic children. Pediatr. Nephrol. 19, 869-873.
Bornefalk, E., Dahlén, I., Michaëlsson, K., Ljunggren, Ö., and Ljunghall,
S. (1998). Age-dependent effect of oral glucocorticoids on markers
of bone resorption in patients with acute asthma. Calcif. Tissue
Int. 63, 9-13.
Bowden, S. A., Akusoba, C. I., Hayes, J. R., and Mahan, J. D. (2016).
Biochemical markers of bone turnover in children with clinical
bone fragility. J. Pediatr. Endocrinol. Metab. 29, 715-722.
Brabnikova Maresova, K., Pavelka, K., and Stepan, J. J. (2013). Acute
effects of glucocorticoids on serum markers of osteoclasts,
osteoblasts, and osteocytes. Calcif. Tissue Int. 92, 354-361.
Chotiyarnwong, P., and McCloskey, E. V. (2020). Pathogenesis of
glucocorticoid-induced osteoporosis and options for treatment. Nat.
Rev. Endocrinol. 16, 437-447.
Compston, J. (2018). Glucocorticoid-induced osteoporosis: an update.
Endocrine 61, 7-16.
Crofton, P. M., Ahmed, S. F., Wade, J. C., Stephen, R., Elmlinger, M.
30
W., Ranke, M. B., Kelnar, C. J., and Wallace, W. H. (1998). Effects
of intensive chemotherapy on bone and collagen turnover and the
growth hormone axis in children with acute lymphoblastic leukemia.
J. Clin. Endocrinol. Metab. 83, 3121-3129.
Crofton, P. M., Evans, N., Taylor, M. R., and Holland, C. V. (2004).
Procollagen type I amino-terminal propeptide: pediatric reference
data and relationship with procollagen type I carboxyl-terminal
propeptide. Clin. Chem. 50, 2173-2176.
Dovio, A., Perazzolo, L., Osella, G., Ventura, M., Termine, A., Milano,
E., Bertolotto, A., and Angeli, A. (2004). Immediate fall of bone
formation and transient increase of bone resorption in the course
of high-dose, short-term glucocorticoid therapy in young patients
with multiple sclerosis. J. Clin. Endocrinol. Metab. 89, 4923-4928.
Godschalk, M. F., and Downs, R. W. (1988). Effect of short-term
glucocorticoids on serum osteocalcin in healthy young men. J. Bone
Miner. Res. 3, 113-115.
Iijima, K., Sako, M., Nozu, K., Mori, R., Tuchida, N., Kamei, K., Miura,
K., Aya, K., Nakanishi, K., Ohtomo, Y., et al. (2014). Rituximab
for childhood-onset, complicated, frequently relapsing nephrotic
syndrome or steroid-dependent nephrotic syndrome: a multicentre,
double-blind, randomised, placebo-controlled trial. The Lancet 384,
1273-1281.
Isojima, T., Kato, N., Ito, Y., Kanzaki, S., and Murata, M. (2016).
Growth standard charts for Japanese children with mean and standard
deviation (SD) values based on the year 2000 national survey. Clin.
Pediatr. Endocrinol. 25, 71-76.
Jürimäe, J. (2010). Interpretation and application of bone turnover
markers in children and adolescents. Curr. Opin. Pediatr. 22, 494500.
Kamei, K., Ishikura, K., Sako, M., Aya, K., Tanaka, R., Nozu, K., Kaito,
H., Nakanishi, K., Ohtomo, Y., Miura, K., et al. (2017). Long-term
outcome of childhood-onset complicated nephrotic syndrome after a
multicenter, double-blind, randomized, placebo-controlled trial of
rituximab. Pediatr. Nephrol. 32, 2071-2078.
Kato, N., Takimoto, H., and Sudo, N. (2011). The cubic functions for
spline smoothed L, S and M values for BMI reference data of
31
Japanese children. Clin. Pediatr. Endocrinol. 20, 47-49.
Leonard, M. B. (2007). Glucocorticoid-induced osteoporosis in children:
impact of the underlying disease. Pediatrics 119 Suppl 2, S166174.
Lips, P., and van Schoor, N. M. (2011). The effect of vitamin D on bone
and osteoporosis. Best Pract. Res. Clin. Endocrinol. Metab. 25,
585-591.
Paglia, F., Dionisi, S., De Geronimo, S., Rosso, R., Romagnoli, E.,
Raejntroph, N., Ragno, A., Celi, M., Pepe, J., D'Erasmo, E., et
al. (2001). Biomarkers of bone turnover after a short period of
steroid therapy in elderly men. Clin. Chem. 47, 1314-1316.
Pocock, N. A., Eisman, J. A., Dunstan, C. R., Evans, R. A., Thomas, D.
H., and Huq, N. L. (1987). Recovery from steroid-induced
osteoporosis. Ann. Intern. Med. 107, 319-323.
Rauchenzauner, M., Schmid, A., Heinz-Erian, P., Kapelari, K.,
Falkensammer, G., Griesmacher, A., Finkenstedt, G., and Högler, W.
(2007). Sex- and age-specific reference curves for serum markers
of bone turnover in healthy children from 2 months to 18 years. J.
Clin. Endocrinol. Metab. 92, 443-449.
Szappanos, A., Toke, J., Lippai, D., Patócs, A., Igaz, P., Szücs, N.,
Füto, L., Gláz, E., Rácz, K., and Tóth, M. (2010). Bone turnover
in patients with endogenous Cushing's syndrome before and after
successful treatment. Osteoporos. Int. 21, 637-645.
Takahashi, T., Okamoto, T., Sato, Y., Hayashi, A., Ueda, Y., and Ariga,
T. (2020). Glucose metabolism disorders in children with
refractory nephrotic syndrome. Pediatr. Nephrol. 35, 649-657.
Takahashi, T., Okamoto, T., Sato, Y., Yamazaki, T., Hayashi, A., Aoyagi,
H., Ueno, M., Kobayashi, N., Uetake, K., Nakanishi, M., et al.
(2019). Periodically repeated rituximab administrations in
children with refractory nephrotic syndrome: 2-year multicenter
observational study. Pediatr. Nephrol. 34, 87-96.
Takahashi, T., Okamoto, T., Yokota, I., Sato, Y., Hayashi, A., Ueda, Y.,
Aoyagi, H., Ueno, M., Kobayashi, N., Uetake, K., et al. (2022).
The effect of rituximab on the quality of life of children with
refractory nephrotic syndrome. Pediatr. Int. 64, e14725.
Tarshish, P., Tobin, J. N., Bernstein, J., and Edelmann, C. M., JR.
32
(1997). Prognostic significance of the early course of minimal
change nephrotic syndrome: report of the International Study of
Kidney Disease in Children. J. Am. Soc. Nephrol. 8, 769-776.
Ton, F. N., Gunawardene, S. C., Lee, H., and Neer, R. M. (2005). Effects
of low-dose prednisone on bone metabolism. J. Bone Miner. Res. 20,
464-470.
Uemura, O., Nagai, T., Ishikura, K., Ito, S., Hataya, H., Gotoh, Y.,
Fujita, N., Akioka, Y., Kaneko, T., and Honda, M. (2014).
Creatinine-based equation to estimate the glomerular filtration
rate in Japanese children and adolescents with chronic kidney
disease. Clin. Exp. Nephrol. 18, 626-633.
Vasikaran, S., Eastell, R., Bruyère, O., Foldes, A. J., Garnero, P.,
Griesmacher, A., McClung, M., Morris, H. A., Silverman, S., Trenti,
T., et al. (2011). Markers of bone turnover for the prediction of
fracture risk and monitoring of osteoporosis treatment: a need for
international reference standards. Osteoporos. Int. 22, 391-420.
Vestergaard, P., Olsen, M. L., Paaske Johnsen, S., Rejnmark, L., Sørensen,
H. T., and Mosekilde, L. (2003). Corticosteroid use and risk of
hip fracture: a population-based case-control study in Denmark. J.
Intern. Med. 254, 486-493.
Vihinen, M. K., Kolho, K. L., Ashorn, M., Verkasalo, M., and Raivio, T.
(2008). Bone turnover and metabolism in paediatric patients with
inflammatory bowel disease treated with systemic glucocorticoids.
Eur. J. Endocrinol. 159, 693-698.
Ward, L. M. (2020). Glucocorticoid-induced osteoporosis: Why kids are
different. Front. Endocrinol. (Lausanne) 11, 576.
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., and Manolagas, S. C.
(1998). Inhibition of osteoblastogenesis and promotion of
apoptosis of osteoblasts and osteocytes by glucocorticoids.
Potential mechanisms of their deleterious effects on bone. J. Clin.
Invest. 102, 274-282.
Wolthers, O. D., Riis, B. J., and Pedersen, S. (1993). Bone turnover in
asthmatic children treated with oral prednisolone or inhaled
budesonide. Pediatr. Pulmonol. 16, 341-346.
33
...
論文の公開元へ
